Maternal chemical and drug intolerances: Potential risk factors for autism and attention deficit hyperactivity disorder (ADHD)

Journal of the American Board of Family Medicine

Volumn 28, Issue 4, 2015, Pages 461-470

  Heilbrun, Lynne P ^a   Palmer, Raymond F ^a   Jaen, Carlos R ^a   Svoboda, Melissa D ^b   Miller, Claudia S ^a   Perkins, Jimmy ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Attention deficit hyperactivity disorder; Autism spectrum disorder; Chemical exposure; Chemical intolerance; Maternal exposure

Indexed keywords

ADULT; ALLERGY; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; FEMALE; FOOD PREFERENCE; HEALTH CARE SURVEY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL CHEMICAL INTOLERANCE; MULTIPLE CHEMICAL SENSITIVITY; ODOR; QUICK ENVIRONMENTAL EXPOSURE AND SENSITIVITY INVENTORY; RATING SCALE; RISK FACTOR; WITHDRAWAL SYNDROME; ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CHILD; CROSS-SECTIONAL STUDY; GENOTYPE ENVIRONMENT INTERACTION; HEALTH SURVEY; MIDDLE AGED; MOTHER; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; DRUG HYPERSENSITIVITY; FEMALE; GENE-ENVIRONMENT INTERACTION; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MOTHERS; MULTIPLE CHEMICAL SENSITIVITY; RISK FACTORS; YOUNG ADULT;

EID: 84937109189     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2015.04.140192     Document Type: Article

References (62)

1. Boyle CA, Boulet SL, Schieve LA, et al. Trends in the prevalence of developmental disabilities in U.S. children, 1997-2008. Pediatrics 2011;127:1034-42.
2. Blumberg SJ, Bramlett MD, Kogan MD, Schieve LA, Jones JR, Lu MC. Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011-2012. Natl Health Stat Report 2013;(65):1-11, 1 p following 11.
3. Hertz-Picciotto I, Delwiche L. The rise in autism and the role of age at diagnosis. Epidemiology 2009;20:84-90.
4. Centers for Disease Control and Prevention (CDC). Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children - United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep 2010;59:1439-43.
5. Toomey SL, Finkelstein J, Kuhlthau K. Does connection to primary care matter for children with attention-deficit/hyperactivity disorder? Pediatrics 2008;122:368-74.
6. Brachlow AE, Ness KK, McPheeters ML, Gurney JG. Comparison of indicators for a primary care medical home between children with autism or asthma and other special health care needs: National Survey of Children's Health. Arch Pediatr Adolesc Med 2007;161(4):399-405.
7. Kogan MD, Strickland BB, Blumberg SJ, Singh GK, Perrin JM, van Dyck PC. A national profile of the health care experiences and family impact of autism spectrum disorder among children in the United States, 2005-2006. Pediatrics 2008;122:e1149-58.
8. Leslie L. The role of primary care physicians in attention deficit hyperactivity disorder (ADHD). Pediatr Ann 2002;31:475-84.
9. Golnick AE, Ireland M. Complementary alternative medicine for children with autism: a physician survey. J Autism Dev Disord 2009;39:996-1005.
10. Hallmayer J, Cleveland S, Torres A, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011;68:1095-102.
11. Wigle DT, Arbuckle TE, Walker M, Wade MG, Liu S, Krewski D. Environmental hazards: evidence for effects on child health. J Toxicol Environ Health B Crit Rev 2007;10:3-39.
12. Pessah I, Seegal RF, Lein PJ, et al. Immunologic and neurodevelopmental susceptibilities of autism. Neurotoxicology 2008;29:532-45.
13. Hertz-Picciotto I, Park HY, Dostal M, Kocan A, Trnovec T, Sram R. Prenatal exposures to persistent and non-persistent organic compounds and effects on immune system development. Basic Clin Pharmacol Toxicol 2008;102:146-54.
14. Rauh VA, Garfinkel R, Perera FP, et al. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics 2006;118:1845-59.
15. Bouchard MF, Bellinger DC, Wright RO, Weisskopf MG. Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides. Pediatrics 2010;125(6):e1270-7.
16. Rosas LG, Eskenazi B. Pesticides and child neurodevelopment. Curr Opin Pediatr 2008;20:191-7.
17. Siddique S, Banerjee M, Ray MR, Lahiri T. Attention-deficit hyperactivity disorder in children chronically exposed to high level of vehicular pollution. Eur J Pediatr 2011;170:923-9.
18. Volk HE, Lurmann F, Penfold B, Hertz-Picciotto I, McConnell R. Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry 2013;70:71-7.
19. Palmer RF, Blanchard S, Wood R. Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place 2009;15:18-24.
20. Weschler CJ. Changes in indoor pollutants since the 1950s. Atmos Environ 2009;43:153-69.
21. Sundell J. Indoor environments and health. Presented at the First International Conference on Sustainable Healthy Buildings, Seoul, Korea, 2009.
22. Kalkbrenner AE, Daniels JL, Chen JC, Poole C, Emch M, Morrissey J. Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8. Epidemiology 2010;21:631-41.
23. Croen L, Grether JK, Yoshida CK, Odouli R, Hendrick V. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 2011;68:1104-12.
24. Figueroa R. Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring. J Dev Behav Pediatr 2010;31:641-8.
25. Strömland V, Nordin M, Miller B, Akerström B, Gillberg C. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 1994;36:351-6.
26. Arndt TL, Stodgell CJ, Rodier PM. The teratology of autism. Int J Dev Neurosci 2005;23:189-99.
27. Bandim JM, Ventura LO, Miller MT, Almeida HC, Costa AE. Autism and Möbius sequence: an exploratory study of children in northeastern Brazil. Arq Neuropsiquiatr. 2003.
28. Moore SJ, Turnpenny P, Quinn A, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 2000;37:489-97.
29. Rodier PM. Converging evidence for brain stem injury in autism. Dev Psychopathol 2002;14:537-57.
30. Kruetzer R, Neutra R, Lashuay N. Prevalence of people reporting sensitivities to chemicals in a population-based survey. Am J Epidemiol 1999;150:1-12.
31. Bell IR, Schwartz GE, Peterson JM, Amend D. Self-reported illness from chemical odors in young adults without clinical syndromes or occupational exposures. Arch Environ Health 1993;48:6-13.
32. Bell IR, Hardin EE, Baldwin CM, Schwartz GE. Increased limbic system symptomatology and sensitizability of young adults with chemical and noise sensitivities. Environ Res 1995;70:84-97.
33. Bell IR, Peterson JM, Schwartz GE. Medical histories and psychological profiles of middle-aged women with and without self-reported illness from environmental chemicals. J Clin Psychiatry 1995;56:151-60.
34. Caress SM, Steinemann AC. A national population study of the prevalence of multiple chemical sensitivity. Arch Intern Med 2004;59:300-5.
35. Katerndahl DA, Bell IR, Palmer RF, Miller GS. Chemical intolerance in primary care settings: prevalence, comorbidity, and outcomes. Ann Fam Med 2012;10:357-65.
36. Miller CS. Toxicant-induced loss of tolerance. Addiction 2001;96:115-37.
37. Miller CS, Prihoda TJ. A controlled comparison of symptoms and chemical intolerances reported by Gulf War veterans, implant recipients and persons with multiple chemical sensitivity. Toxicol Ind Health 1999;15:386-97.
38. Miller CS, Prihoda TJ. The Environmental Exposure and Sensitivity Inventory (EESI): a standardized approach for measuring chemical intolerances for research and clinical applications. Toxicol Ind Health 1999;15:370-85.
39. Hojo S, Kumano H, Yoshino H, Kakuta K, Ishikawa S. Application of Quick Environment Exposure Sensitivity Inventory (QEESI) for Japanese population: study of reliability and validity of the questionnaire. Toxicol Ind Health 2003;19:41-9.
40. Schnakenberg E, Fabig KR, Stanulla M, et al. A cross-sectional study of self-reported chemical-related sensitivity is associated with gene variants of drug-metabolizing enzymes. Environ Health 2007;6:6.
41. Skovbjerg S, Berg ND, Elberling J, Christensen KB. Evaluation of the Quick Environmental Exposure and Sensitivity Inventory in a Danish population. J Environ Public Health 2012;2012:304314.
42. Lee H, Marvin AR, Watson T, et al. Accuracy of phenotyping of autistic children based on internet implemented parent report. Am J Med Genet B Neuropsychatr Genet 2010;153B:1119-26.
43. Daniels AM, Rosenberg RE, Anderson C, Law JK, Marvin AR, Law PA. Verification of parent-report of child autism spectrum disorder diagnosis to a web-based autism registry. J Autism Dev Disord 2012;42:257-65.
44. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition, text rev. Washington, DC: APA; 2000.
45. Westfall PH, Tobias RD, Rom D, Wolfinger RD, Hochberg Y. Multiple comparisons and multiple tests using the SAS system. Cary, NC: SAS Institute; 1999.
46. Lajiness-O'Neill R, Menard P. Brief report: an autistic spectrum subtype revealed through familial psychopathology coupled with cognition in ASD. J Autism Dev Disord 2008;38:982-7.
47. Schachar RJ, Wachsmuth R. Hyperactivity and parental psychopathology. J Child Psychol Psychiatry 1990;31:381-92.
48. Davis C, Curtis C, Levitan RD, Carter JC, Kaplan AS, Kennedy JL. Evidence that "food addiction" is a valid phenotype of obesity. Appetite 2011;57:711-7.
49. Gruss B, Mueller A, Horbach T, Martin A, de Zwaan M. Attention-deficit/hyperactivity disorder in a prebariatric surgery sample. Eur Eat Disord Rev 2012;20:e103-7.
50. Macfabe D. Autism: metabolism, mitochondria, and the microbiome. Glob Adv Health Med 2013;2:52-66.
51. De Luca C, Gugliandolo A, Calabrò C, Currò M, Ientile R, Raskovic D, et al. Role of polymorphisms of inducible nitric oxide synthase and endothelial nitric oxide synthase in idiopathic environmental intolerances. Mediators Inflamm. 2015; Epub 2015 Mar 24.
52. Gaita L, Manzi B, Sacco R, et al. Decreased serum arylesterase activity in autism spectrum disorders. Psychiatry Res 2010;180:105-13.
53. Furlong CE, Holland N, Richter RJ, Bradman A, Ho A, Eskenazi B. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity. Pharmacogenet Genomics 2006;16:183-90.
54. Singh S, Kumar V, Thakur S, et al. DNA damage and cholinesterase activity in occupational workers exposed to pesticides. Environ Toxicol Pharmacol 2011;31:278-85.
55. Singh S, Kumar V, Thakur S, et al. Paraoxonase-1 genetic polymorphisms and susceptibility to DNA damage in workers occupationally exposed to organophosphate pesticides. Toxicol Appl Pharmacol 2011;252:130-7.
56. Kozhimannil KB, Fontaine P. Care from family physicians reported by pregnant women in the United States. Ann Fam Med 2013;11:350-4.
57. American College of Obstetricians and Gynecologists. Exposure to toxic environmental agents. Washington DC: ACOG; 2013.
58. Mickelson KD. Seeking social support: parents in electronic support groups. Culture of the Internet. Mahwah, NJ: Erlbaum;1997:157-78.
59. Losh SC. Generation, education, gender and ethnicity in American digital divides. In: Handbook of research on overcoming digital divides: constructing an equitable and competitive information society. Vol. 1. Hershey, PA: IGI Global;2009:196-222.
60. Mickelson KD, Wroble M, Helgeson VS. "Why my child?": parental attributions for children's special needs1. J Applied Soc Psychol 1999;29:1263-91.
61. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies: III. Design options. Am J Epidemiol 1992;135:1042-50.
62. Miller CS and Mitzel HC. Chemical sensitivity attributed to pesticide exposure versus remodeling. Arch Environ Health. 1995;50:119-29.